<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="editorial" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JNCI Cancer Spectr</journal-id><journal-id journal-id-type="iso-abbrev">JNCI Cancer Spectr</journal-id><journal-id journal-id-type="pmc-domain-id">3695</journal-id><journal-id journal-id-type="pmc-domain">jncicanspec</journal-id><journal-id journal-id-type="publisher-id">jncics</journal-id><journal-title-group><journal-title>JNCI Cancer Spectrum</journal-title></journal-title-group><issn pub-type="epub">2515-5091</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11009462</article-id><article-id pub-id-type="pmcid-ver">PMC11009462.1</article-id><article-id pub-id-type="pmcaid">11009462</article-id><article-id pub-id-type="pmcaiid">11009462</article-id><article-id pub-id-type="pmid">38605595</article-id><article-id pub-id-type="doi">10.1093/jncics/pkae024</article-id><article-id pub-id-type="publisher-id">pkae024</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00010</subject></subj-group></article-categories><title-group><article-title>Increased pain in veterans with cancer&#8212;time to re-evaluate opioid prescribing practices?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6602-7204</contrib-id><name name-style="western"><surname>Jairam</surname><given-names initials="V">Vikram</given-names></name><degrees>MD</degrees><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft">Writing - original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org" vocab-term="Writing - review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing">Writing - review &amp; editing</role><xref rid="pkae024-cor1" ref-type="corresp"/><aff>
<institution>Department of Radiation Oncology, Sutter Medical Group</institution>, Sacramento, CA, <country country="US">USA</country></aff></contrib></contrib-group><author-notes><corresp id="pkae024-cor1"><bold>Correspondence to:</bold> Vikram Jairam, MD, Department of Radiation Oncology, Sutter Medical Group, 2825 Capitol Ave 6th Floor, Sacramento, CA 95816, USA (e-mail: <email>vikram.jairam@sutterhealth.org</email>).</corresp></author-notes><pub-date pub-type="collection"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-04-11"><day>11</day><month>4</month><year>2024</year></pub-date><volume>8</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">456841</issue-id><elocation-id>pkae024</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>12</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-24 17:25:13.990"><day>24</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024. Published by Oxford University Press.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="pkae024.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pkae024.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="research-article" journal-id="JNCI Cancer Spectr" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11009465"><article-title>Opioid use in cancer patients compared with noncancer pain patients in a veteran population</article-title><volume>8</volume><issue>2</issue><date><day>8</day><month>3</month><year>2024</year></date><elocation-id>pkae012</elocation-id><source>JNCI Cancer Spectrum</source><pub-id pub-id-type="doi">10.1093/jncics/pkae012</pub-id><pub-id pub-id-type="pmcid">PMC11009465</pub-id><pub-id pub-id-type="pmid">38457606</pub-id></related-article><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="companion" xml:lang="en" xlink:title="research-article" journal-id="JNCI Cancer Spectr" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11009465"><article-title>Opioid use in cancer patients compared with noncancer pain patients in a veteran population</article-title><volume>8</volume><issue>2</issue><date><day>8</day><month>3</month><year>2024</year></date><elocation-id>pkae012</elocation-id><source>JNCI Cancer Spectrum</source><pub-id pub-id-type="doi">10.1093/jncics/pkae012</pub-id><pub-id pub-id-type="pmcid">PMC11009465</pub-id><pub-id pub-id-type="pmid">38457606</pub-id></related-article><counts><page-count count="2"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>The United States is in the middle of an opioid epidemic. The number of opioid-related overdose deaths in 2021 was at its highest in any year, claiming more than 80&#8202;000 lives (<xref rid="pkae024-B1" ref-type="bibr">1</xref>). This is primarily due to an increase in synthetic opioids, such as fentanyl, responsible for 70&#8202;000 overdose-related deaths. Meanwhile, prescription opioid deaths rose steadily from 2000 and peaked in 2017, now having decreased and stabilized since then. This is in large part due to increased regulation and scrutiny of opioid prescribing, with initiatives such as prescription drug monitoring programs, temporal limits on initial opioid prescriptions, insurance-related prior authorizations, and national clinical practice guidelines (<xref rid="pkae024-B2" ref-type="bibr">2</xref>,<xref rid="pkae024-B3" ref-type="bibr">3</xref>). In addition, there has been a marked change in attitudes of prescribers toward opioid prescribing, with a heightened concern for high-risk use and misuse (<xref rid="pkae024-B4" ref-type="bibr">4</xref>). As a result, there was a 20% decrease in opioid prescribing nationwide between 2013 and 2017 (<xref rid="pkae024-B5" ref-type="bibr">5</xref>).</p><p>Veterans represent a unique population who are particularly prone to experiencing chronic pain compared with the general population, in part due to the physical and mental demands of military service (<xref rid="pkae024-B6" ref-type="bibr">6</xref>). In turn, high-risk opioid use is especially prevalent in this population (<xref rid="pkae024-B7" ref-type="bibr">7</xref>). In 2013, the Veterans Health Administration (VHA) launched the Opioid Safety Initiative, aimed to ensure veterans are prescribed opioids in a safe and effective manner. However, there is a paucity of long-term data describing patterns of opioid prescribing and how this has impacted pain control. This question is of particular interest in patients with cancer and cancer survivors, who have unique pain management needs that may be impacted by well-intentioned initiatives curbing opioid prescribing.</p><p>To study this, Mudumbai and colleagues explored patterns of opioid prescribing and pain in a population of veterans at a tertiary VHA system between 2015 and 2021 (<xref rid="pkae024-B8" ref-type="bibr">8</xref>). Patient demographic and medical history was extracted from electronic health records along with opioid prescription data. Opioid prescriptions of 30, 60, and 90 consecutive days along with average morphine milligram equivalents (MME) per year were calculated. Cancer incidence was obtained from a linked database and included all cancer diagnoses except benign lesions and nonmelanoma skin cancers. The highest pain score for a patient recorded in a given year was used to determine pain level. Patterns among patients with and without cancer were compared.</p><p>As expected, the authors found patients with cancer were more likely to receive an opioid prescription and had a higher average MME compared to noncancer patients. Perhaps the most salient findings of the study pertain to the temporal trends in opioid prescribing and incidence of severe pain. The study reports significant decreases in opioid prescribing with an average 60% decrease per year in MME in both cohorts. This decrease accelerated more in the last 2 years of the study in patients with cancer compared to noncancer patients. When pain scores were evaluated, there was a concerning increase in the incidence of severe pain from 29.5% to 31.9% among patients with cancer, whereas this rate remained steady (27.4%) among noncancer patients.</p><p>This study raises a critical issue regarding the appropriateness of shifting prescribing patterns among patients with cancer. Although it is known that opioid prescribing and utilization have decreased among cancer survivors (<xref rid="pkae024-B5" ref-type="bibr">5</xref>,<xref rid="pkae024-B10" ref-type="bibr">10</xref>,<xref rid="pkae024-B11" ref-type="bibr">11</xref>), there is a growing body of data to suggest this paradigm shift may not reflect appropriate changes in clinical practice. Multiple studies have found that reduced opioid prescribing in patients with cancer has led to worse pain control (<xref rid="pkae024-B11" ref-type="bibr">11</xref>), is not tailored to patients at highest risk of misuse (<xref rid="pkae024-B12" ref-type="bibr">12</xref>), and is more prevalent among racial and ethnic minorities (<xref rid="pkae024-B13" ref-type="bibr">13</xref>,<xref rid="pkae024-B14" ref-type="bibr">14</xref>). Notably, this study by Mudumbai and colleagues is unique in evaluating pain in the outpatient setting and including a noncancer comparison group. It suggests that efforts toward reduced opioid prescribing are leading to higher levels of uncontrolled pain among patients with cancer. Indeed, there is growing concern that tighter regulations and heightened scrutiny associated with opioid prescribing has inadvertently impacted pain control among cancer survivors (<xref rid="pkae024-B15" ref-type="bibr">15-17</xref>). In 2022, this led the Centers for Disease Control and Prevention to amend its 2016 clinical practice guidelines for opioid prescribing in patients with pain to more explicitly emphasize individualized decision-making and exclude patients with cancer-related pain (<xref rid="pkae024-B18" ref-type="bibr">18</xref>).</p><p>As the authors note, there are some limitations of this study, as well as questions this study raises for further exploration. First, this was conducted at a single VHA tertiary care hospital and may not reflect practice patterns among all veterans. Efforts are underway to expand this study to a broader range of VHA centers. Second, although the study suggests a potential correlation between decreasing opioid prescribing and increasing pain scores, there may be other etiologies contributing to the increase in severe pain. For example, improvements in life expectancy and cancer treatments have resulted in more cancer survivors, particularly elderly patients, living longer and with lasting side effects from their disease or treatments, including chronic pain (<xref rid="pkae024-B19" ref-type="bibr">19</xref>). Adults aged 85&#8201;years and older are the fastest-growing group of cancer survivors, and it is known that cancer-related pain is woefully undertreated in elderly patients (<xref rid="pkae024-B20" ref-type="bibr">20</xref>). Future studies could explore more granular measures of pain and particular subgroups of patients with cancer. For example, an analysis of the average or median pain scores for a patient within a given year may provide a meaningful assessment of overall symptom control and minimize the impact of outlier events. In addition, a study of pain scores in patients whose opioid prescriptions remained steady over time may help clarify the association between opioid prescribing and pain control. Finally, it would be informative to understand how opioid prescribing patterns and pain scores differ among patients with localized vs metastatic disease, as these comprise separate populations with different pain management needs.</p></body><back><sec sec-type="data-availability"><title>Data availability</title><p>No new data were generated or analyzed for this editorial.</p></sec><sec><title>Author contributions</title><p>Vikram Jairam, MD (Conceptualization; Writing&#8212;original draft; Writing&#8212;review &amp; editing).</p></sec><sec><title>Funding</title><p>No funding was used for this editorial.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>Vikram Jairam reports no disclosures.</p></sec><ref-list id="ref1"><title>References</title><ref id="pkae024-B1"><label>1</label><mixed-citation publication-type="other"><collab>National Institute on Drug Abuse</collab>. <italic toggle="yes">Drug Overdose Death Rates</italic>. February 9, <year>2023</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates" ext-link-type="uri">https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates</ext-link>. Accessed May 21, 2023.</mixed-citation></ref><ref id="pkae024-B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Davis</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Lieberman</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Hernandez-Delgado</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Suba</surname><given-names>C.</given-names></string-name></person-group><article-title>Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review</article-title>. <source>Drug Alcohol Depend</source>. <year>2019</year>;<volume>194</volume>:<fpage>166</fpage>-<lpage>172</lpage>.<pub-id pub-id-type="pmid">30445274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2018.09.022</pub-id></mixed-citation></ref><ref id="pkae024-B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Dowell</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname><given-names>R.</given-names></string-name></person-group><article-title>CDC guideline for prescribing opioids for chronic pain&#8212;United States, 2016</article-title>. <source>JAMA</source>. <year>2016</year>;<volume>315</volume>(<issue>15</issue>):<fpage>1624</fpage>-<lpage>1645</lpage>.<pub-id pub-id-type="pmid">26977696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.1464</pub-id><pub-id pub-id-type="pmcid">PMC6390846</pub-id></mixed-citation></ref><ref id="pkae024-B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Razouki</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Khokhar</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Philpot</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Ebbert</surname><given-names>JO.</given-names></string-name></person-group><article-title>Attributes, attitudes, and practices of clinicians concerned with opioid prescribing</article-title>. <source>Pain Med</source>. <year>2019</year>;<volume>20</volume>(<issue>10</issue>):<fpage>1934</fpage>-<lpage>1941</lpage>.<pub-id pub-id-type="pmid">30403814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pny204</pub-id></mixed-citation></ref><ref id="pkae024-B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jairam</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>DX</given-names></string-name>, <string-name name-style="western"><surname>Pasha</surname><given-names>S</given-names></string-name></person-group>, <etal>et al</etal><article-title>Temporal trends in opioid prescribing patterns among oncologists in the Medicare population</article-title>. <source>J Natl Cancer Inst</source>. <year>2020</year>;<volume>113</volume>(<issue>3</issue>):<fpage>274</fpage>-<lpage>281</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djaa110</pub-id><pub-id pub-id-type="pmcid">PMC7936059</pub-id><pub-id pub-id-type="pmid">32785685</pub-id></mixed-citation></ref><ref id="pkae024-B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nahin</surname><given-names>RL.</given-names></string-name></person-group><article-title>Severe pain in veterans: the effect of age and sex, and comparisons with the general population</article-title>. <source>J Pain</source>. <year>2017</year>;<volume>18</volume>(<issue>3</issue>):<fpage>247</fpage>-<lpage>254</lpage>.<pub-id pub-id-type="pmid">27884688</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpain.2016.10.021</pub-id><pub-id pub-id-type="pmcid">PMC5337168</pub-id></mixed-citation></ref><ref id="pkae024-B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bennett</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Guarino</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Britton</surname><given-names>PC</given-names></string-name></person-group>, <etal>et al</etal><article-title>U.S. military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts</article-title>. <source>Ann Med</source>. <year>2022</year>;<volume>54</volume>(<issue>1</issue>):<fpage>1826</fpage>-<lpage>1838</lpage>.<pub-id pub-id-type="pmid">35792749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07853890.2022.2092896</pub-id><pub-id pub-id-type="pmcid">PMC9262363</pub-id></mixed-citation></ref><ref id="pkae024-B8"><label>8</label><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name name-style="western"><surname>Mudumbai</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>JQ</given-names></string-name></person-group>, <etal>et al</etal> Opioid use in cancer patients compared with noncancer pain patients in a veteran population. <italic toggle="yes">JNCI Cancer Spectr</italic>. <year>2024</year>. doi:<pub-id pub-id-type="doi">10.1093/jncics/pkae012</pub-id><pub-id pub-id-type="pmcid">PMC11009465</pub-id><pub-id pub-id-type="pmid">38457606</pub-id></mixed-citation></ref><ref id="pkae024-B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Agarwal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Dusetzina</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Royce</surname><given-names>TJ.</given-names></string-name></person-group><article-title>Changes in opioid prescribing patterns among generalists and oncologists for Medicare part D beneficiaries from 2013 to 2017</article-title>. <source>JAMA Oncol</source>. <year>2020</year>;<volume>6</volume>(<issue>8</issue>):<fpage>1271</fpage>-<lpage>1274</lpage>.<pub-id pub-id-type="pmid">32469405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2020.2211</pub-id><pub-id pub-id-type="pmcid">PMC7260690</pub-id></mixed-citation></ref><ref id="pkae024-B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Baum</surname><given-names>LVM</given-names></string-name>, <string-name name-style="western"><surname>Kc</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Soulos</surname><given-names>PR</given-names></string-name></person-group>, <etal>et al</etal><article-title>Trends in new and persistent opioid use in older adults with and without cancer</article-title>. <source>J Natl Cancer Inst</source>. <year>2024</year>;116(2):<fpage>316</fpage>-<lpage>323</lpage>.<pub-id pub-id-type="pmid">37802882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djad206</pub-id></mixed-citation></ref><ref id="pkae024-B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Enzinger</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Ghosh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Keating</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Cutler</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Landrum</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>AA.</given-names></string-name></person-group><article-title>US trends in opioid access among patients with poor prognosis cancer near the end-of-life</article-title>. <source>J Clin Oncol</source>. <year>2021</year>;<volume>39</volume>(<issue>26</issue>):<fpage>2948</fpage>-<lpage>2958</lpage>.<pub-id pub-id-type="pmid">34292766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.21.00476</pub-id><pub-id pub-id-type="pmcid">PMC8425843</pub-id></mixed-citation></ref><ref id="pkae024-B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Townsend</surname><given-names>TN</given-names></string-name>, <string-name name-style="western"><surname>Salz</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Haffajee</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Caram</surname><given-names>MEV</given-names></string-name>, <string-name name-style="western"><surname>Chino</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bohnert</surname><given-names>ASB.</given-names></string-name></person-group><article-title>Has declining opioid dispensing to cancer patients been tailored to risk of opioid harms?</article-title><source>J Pain Symptom Manage</source>. <year>2022</year>;<volume>63</volume>(<issue>2</issue>):<fpage>179</fpage>-<lpage>188</lpage>.<pub-id pub-id-type="pmid">34656655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpainsymman.2021.09.014</pub-id><pub-id pub-id-type="pmcid">PMC8816811</pub-id></mixed-citation></ref><ref id="pkae024-B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Vitzthum</surname><given-names>LK</given-names></string-name>, <string-name name-style="western"><surname>Nalawade</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Riviere</surname><given-names>P</given-names></string-name></person-group>, <etal>et al</etal><article-title>Racial, ethnic, and socioeconomic discrepancies in opioid prescriptions among older patients with cancer</article-title>. <source>J Clin Oncol Oncol Pract</source>. <year>2021</year>;<volume>17</volume>(<issue>6</issue>):<fpage>e703</fpage>-<lpage>e713</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/OP.20.00773</pub-id><pub-id pub-id-type="pmcid">PMC8258011</pub-id><pub-id pub-id-type="pmid">33534647</pub-id></mixed-citation></ref><ref id="pkae024-B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Enzinger</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Ghosh</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Keating</surname><given-names>NL</given-names></string-name></person-group>, <etal>et al</etal><article-title>Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of life</article-title>. <source>J Clin Oncol</source>. <year>2023</year>;<volume>41</volume>(<issue>14</issue>):<fpage>2511</fpage>-<lpage>2522</lpage>.<pub-id pub-id-type="pmid">36626695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.22.01413</pub-id><pub-id pub-id-type="pmcid">PMC10414726</pub-id></mixed-citation></ref><ref id="pkae024-B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rubin</surname><given-names>R.</given-names></string-name></person-group><article-title>Limits on opioid prescribing leave patients with chronic pain vulnerable</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>321</volume>(<issue>21</issue>):<fpage>2059</fpage>-<lpage>2062</lpage>.<pub-id pub-id-type="pmid">31034007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.5188</pub-id></mixed-citation></ref><ref id="pkae024-B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Meghani</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Vapiwala</surname><given-names>N.</given-names></string-name></person-group><article-title>Bridging the critical divide in pain management guidelines from the CDC, NCCN, and ASCO for cancer survivors</article-title>. <source>JAMA Oncol</source>. <year>2018</year>;<volume>4</volume>(<issue>10</issue>):<fpage>1323</fpage>-<lpage>1324</lpage>.<pub-id pub-id-type="pmid">29852051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaoncol.2018.1574</pub-id></mixed-citation></ref><ref id="pkae024-B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Page</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Blanchard</surname><given-names>E.</given-names></string-name></person-group><article-title>Opioids and cancer pain: patients&#8217; needs and access challenges</article-title>. <source>J Oncol Pract</source>. <year>2019</year>;<volume>15</volume>(<issue>5</issue>):<fpage>229</fpage>-<lpage>231</lpage>.<pub-id pub-id-type="pmid">31013181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JOP.19.00081</pub-id></mixed-citation></ref><ref id="pkae024-B18"><label>18</label><mixed-citation publication-type="other"><collab>Centers for Disease Control and Prevention</collab>. <italic toggle="yes">CDC Clinical Practice Guideline for Prescribing Opioids for Pain&#8211;United States, 2022.</italic> November 4, <year>2022</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm?s_cid=rr7103a1_w" ext-link-type="uri">https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm?s_cid=rr7103a1_w</ext-link>. Accessed June 9, 2023.</mixed-citation></ref><ref id="pkae024-B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>DeSantis</surname><given-names>CE</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Dale</surname><given-names>W</given-names></string-name></person-group>, <etal>et al</etal><article-title>Cancer statistics for adults aged 85 years and older, 2019</article-title>. <source>CA Cancer J Clin</source>. <year>2019</year>;<volume>69</volume>(<issue>6</issue>):<fpage>452</fpage>-<lpage>467</lpage>.<pub-id pub-id-type="pmid">31390062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21577</pub-id><pub-id pub-id-type="pmcid">PMC12103238</pub-id></mixed-citation></ref><ref id="pkae024-B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bernabei</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Gambassi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lapane</surname><given-names>K</given-names></string-name></person-group>, <etal>et al</etal><article-title>Management of pain in elderly patients with cancer</article-title>. <source>JAMA</source>. <year>1998</year>;<volume>279</volume>(<issue>23</issue>):<fpage>1877</fpage>-<lpage>1882</lpage>.<pub-id pub-id-type="pmid">9634258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.279.23.1877</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>